Corixa reports Q2 rev. $5.8 mln, down YoY, net loss $10.6 mln.

sábado, 17 de enero de 2026, 4:15 pm ET1 min de lectura
GSK--

• Corixa reports Q2 revenue of $5.8 million, down from $20 million in Q2 2003. • Revenue decrease due to one-time milestone and reimbursement revenue from GSK. • Q2 net loss applicable to common stockholders is $10.6 million.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios